Latest News

On October 31, 2025, SBI Holdings announced a second-quarter dividend increase to ¥40.00 per share, up from ¥30.00 a year earlier, and the board approved a stock split and amendments to the company’s Articles of Incorporation. This combination of a higher dividend payout and a stock split reflects growing management confidence and may broaden appeal for a more diverse investor base. We'll examine how the board-approved stock split and dividend hike could shape SBI Holdings' investment...

In recent trading, TOWA shares were actively purchased to their maximum limit after the company posted first-half consolidated operating profit results that, while down year-on-year, significantly outperformed internal forecasts. This strong investor response highlights how positive surprises in financial reporting can outweigh a drop in profits, especially when sentiment for technology and semiconductor stocks is high across the broader market. With first-half profits exceeding...

Finning International (TSX:FTT) is gearing up to release its third quarter results, and there is a lot of attention on the numbers. Analyst forecasts point to a meaningful revenue drop from last year. See our latest analysis for Finning International. Finning International's share price has posted an impressive 96% gain since the start of the year, with a 26.5% climb over the past three months alone. This upbeat momentum reflects renewed confidence in the company's outlook, even as the...

On October 31, 2025, TIS Inc. raised its consolidated earnings guidance for the fiscal year ending March 31, 2026, projecting net sales of ¥588.00 billion and operating profit of ¥75.00 billion, alongside announcing a second-quarter dividend increase to ¥38 per share, payable December 5, 2025. This combination of upward earnings revision and a higher dividend signals management’s increased optimism about the company's outlook and operational momentum. We’ll examine how the raised full-year...

Kaspi.kz (NasdaqGS:KSPI) has just released its third quarter and year-to-date 2025 earnings, showing a marked increase in revenue compared to the previous year. This latest financial update is drawing investor attention. See our latest analysis for Kaspi.kz. Kaspi.kz’s solid earnings have landed just as the stock has seen some sharp swings. The year-to-date share price return sits at -26.05%, while the total shareholder return over the past year is down 33.25%. Momentum remains challenged,...

Akebia Therapeutics (AKBA) just posted third quarter 2025 earnings, swinging from a net loss to net profit as a result of much higher revenue. Investors are watching closely because this marks a financial turnaround for the company. See our latest analysis for Akebia Therapeutics. Akebia’s share price has taken a hit recently. Even after swinging to profit this quarter, it fell 18% in the past day and is down 39% over the last month as investors digested mixed clinical trial updates and...

In recent days, Deutsche Bank Aktiengesellschaft announced and completed multiple fixed-income offerings, issuing senior unsubordinated unsecured notes with varying maturities and fixed coupon rates, including callable Eurobonds spanning from 2030 to 2050. This concentration of bond issuances highlights the bank's active pursuit of capital-raising through debt markets as it refines its funding strategy and addresses investor demand for fixed-income securities. We'll explore how Deutsche...

Citigroup recently expanded its Citi Token Services platform to support Euro transactions, extending operations to Dublin, Ireland and further broadening its global, real-time cross-border payment capabilities for corporate and institutional clients. This move marks a key advance in Citigroup's digital asset strategy, combining enhanced liquidity with ongoing investments in artificial intelligence and technological innovation. We’ll now explore how the launch of Euro-enabled Citi Token...

Alexander's, Inc. recently reported third-quarter earnings, noting sales of US$53.42 million and net income of US$5.97 million, both lower than the prior year's results, and reaffirmed a quarterly dividend of US$4.50 per share payable later this month. Despite these year-over-year declines in sales and earnings, strong analyst sentiment has led to an upward revision in full-year earnings estimates and elevated the company to a top ranking by Zacks. We'll examine how the improved analyst...

Bank of Qingdao (SEHK:3866) just revealed its earnings for the nine months ended September, showing higher net interest income and net profit compared to last year. This improvement in profitability is sparking new attention from investors. See our latest analysis for Bank of Qingdao. The latest earnings boost seems to have fueled confidence in Bank of Qingdao, with the share price up 45% year to date. Looking at the bigger picture, the bank’s one-year total shareholder return is an...

Dianthus Therapeutics (DNTH) caught investor attention after announcing statistically significant positive results from its Phase 2 trial for claseprubart in generalized myasthenia gravis. The company now plans to launch Phase 3 studies. See our latest analysis for Dianthus Therapeutics. The market has clearly taken notice of Dianthus Therapeutics’ recent milestones. The share price is up nearly 84% over the past 90 days, and there has been a robust year-to-date increase of 58% following...

Rithm Capital Corp. recently reported earnings for the six months ended September 30, 2025, posting net income of US$221.54 million with basic earnings per share from continuing operations of US$0.36. Although the company highlighted strong results, it also disclosed substantial acquisition integration risks and insider share sales, raising questions about upcoming challenges and executive confidence. We'll now explore how the integration risks from recent acquisitions may shape Rithm...

China Hanking Holdings (SEHK:3788) just received regulatory approval to begin dewatering work at its Golden Pig gold mine in Western Australia. This step clears the way for starting underground mining operations as part of its broader Cygnet gold project plans. See our latest analysis for China Hanking Holdings. Momentum has been building fast for China Hanking Holdings, as its regulatory win in Australia comes alongside a stunning 450.65% year-to-date share price return and a 412.24% total...

Microvast Holdings (MVST) just released its third quarter results, highlighting a jump in sales and a sharp reduction in year-to-date net losses. Investors are watching closely to see how these numbers influence momentum. See our latest analysis for Microvast Holdings. The latest earnings news comes on the heels of an impressive run for Microvast Holdings, as the 1-year total shareholder return stands at a staggering 2,455%. After some recent volatility and a sharp 7-day pullback, the 90-day...

Cellebrite DI (CLBT) has been attracting interest given its recent share movement and the company's evolving position in digital intelligence solutions. Investors have noticed the stock’s mixed performance over the past month and year, which is driving conversation about future prospects. See our latest analysis for Cellebrite DI. Momentum around Cellebrite DI has seen its ups and downs, with a sharp 18.3% dip in the past month hinting at shaken confidence. However, the company’s longer-term...

Tyson Foods (TSN) shares have been on investors’ radars recently, especially as the stock’s returns over the past month show a modest recovery. For those interested in the food sector, the company’s recent performance raises interesting questions about its value and future prospects. See our latest analysis for Tyson Foods. Tyson Foods has seen a modest rebound lately, with a 4.4% 7-day share price return adding to positive momentum after a weak first quarter. Despite recent gains, the...

IRADIMED CORPORATION recently reported third quarter and nine-month 2025 results, revealing year-over-year growth in revenue and net income, and raised its full-year 2025 revenue and earnings guidance. The company’s ability to lift full-year projections after another period of double-digit sales growth highlights management’s confidence in ongoing demand for its MRI-compatible medical devices. We’ll explore how IRADIMED’s raised guidance could influence its long-term growth narrative and...

Invesco Ltd. recently reported third quarter results, showing significant year-over-year growth in both revenue and net income, alongside a new share repurchase update and quarterly dividend affirmations for both common and preferred shareholders. The company also indicated an ongoing focus on mergers and acquisitions in private markets, highlighting $130 billion in assets and future growth ambitions in this segment. We'll explore how this strong earnings growth and expanding private markets...

Wondering if W. P. Carey is still a bargain or if its recent run means you might be late to the party? You're not alone. Knowing whether to buy, hold, or move on all starts with nailing down what the stock is really worth. After a solid 27.2% gain over the last year and a jump of 23.2% year-to-date, W. P. Carey's stock clearly hasn't gone unnoticed, with buyers and risk-takers eyeing the momentum. Some of the recent uptick can be traced to sector-wide moves in commercial real estate and...

Karoon Energy announced in October 2025 that Ms Carri Lockhart would become its new CEO and Managing Director from November 3, 2025, following the resignation of Dr Julian Fowles. Ms Lockhart's appointment brings more than 30 years of global oil and gas experience to Karoon, with a history of leading major operations and significant board expertise across the energy sector. We'll examine how Ms Lockhart's international leadership and operational track record could influence Karoon Energy's...

The FDA’s recent approval for a label update on CARVYKTI, Legend Biotech (LEGN)’s flagship therapy, highlights promising survival benefits for patients with relapsed, refractory multiple myeloma. This regulatory milestone could influence the company's future outlook. See our latest analysis for Legend Biotech. Legend Biotech’s latest FDA win for CARVYKTI appears to have injected some confidence into the long-term story. However, short-term share price returns tell a more muted tale, with the...

Integer Holdings (ITGR) just revealed a major update for its investors, announcing a share buyback program of up to $200 million. The program will be funded mainly by available cash and free cash flow. This move is likely to catch the market’s attention given its scale and funding approach. See our latest analysis for Integer Holdings. Integer Holdings’ buyback announcement lands after a challenging stretch, with the share price down nearly 32% in the last month and a year-to-date price...

The United Kingdom's FTSE 100 index recently experienced a downturn, influenced by weak trade data from China and declining commodity prices impacting major mining companies. As the market grapples with these global economic challenges, identifying undervalued stocks becomes crucial for investors seeking potential opportunities.

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting the global interconnectedness of economies. In such a volatile environment, growth stocks with high insider ownership can be particularly appealing as they often indicate confidence in the company's future prospects by those who know it best.